0001209191-19-059767.txt : 20191209
0001209191-19-059767.hdr.sgml : 20191209
20191209183641
ACCESSION NUMBER: 0001209191-19-059767
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191205
FILED AS OF DATE: 20191209
DATE AS OF CHANGE: 20191209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Oney Sabah
CENTRAL INDEX KEY: 0001757776
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38792
FILM NUMBER: 191276264
MAIL ADDRESS:
STREET 1: C/O ALECTOR, INC.
STREET 2: 151 OYSTER POINT BLVD., #300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alector, Inc.
CENTRAL INDEX KEY: 0001653087
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 462702363
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 151 OYSTER POINT BLVD., SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-231-5660
MAIL ADDRESS:
STREET 1: 151 OYSTER POINT BLVD., SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: Alector LLC
DATE OF NAME CHANGE: 20150915
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-12-05
0
0001653087
Alector, Inc.
ALEC
0001757776
Oney Sabah
C/O ALECTOR, INC.
131 OYSTER POINT BLVD, SUITE 600
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Business Officer
Common Stock
2019-12-05
4
M
0
1500
8.16
A
595418
D
Common Stock
2019-12-05
4
S
0
1500
20.00
D
593918
D
Common Stock
2019-12-06
4
M
0
5156
8.16
A
599074
D
Common Stock
2019-12-06
4
S
0
5156
20.02
D
593918
D
Common Stock
2019-12-09
4
M
0
2300
8.16
A
596218
D
Common Stock
2019-12-09
4
S
0
2300
20.07
D
593918
D
Stock Option (right to buy)
8.16
2019-12-05
4
M
0
1500
0.00
D
2028-07-01
Common Stock
1500
148100
D
Stock Option (right to buy)
8.16
2019-12-06
4
M
0
5156
0.00
D
2028-07-01
Common Stock
5156
142944
D
Stock Option (right to buy)
8.16
2019-12-09
4
M
0
2300
0.00
D
2028-07-01
Common Stock
2300
140644
D
The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan.
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $20.00 to $20.005 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $20.00 to $20.09 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $20.00 to $20.24 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
One forty-eighth (1/48th) of the shares subject to the option vested on August 2, 2018, and an additional one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
/s/ Stephanie Yonker, attorney-in-fact
2019-12-09